Outline* The shown information is the one as of the awarded date and might has been changed.
Primary use of our “JPAP” would be at home to treat patients with Sleep Apnea Syndrome (SAS) who experience repeated episodes of complete or partial blockage of the upper airway due to certain physical condition or because of respiratory center abnormity, which causes decreased Oxygen saturation level in the blood that leads to poor quality of sleep and could be an eventual cause of a variety of adult diseases. We are the only company in Japan who develops and manufactures this type of product utilizing own proprietary technology and is an ideal solution for ensuring high quality of sleep.
Kazufuku Nitta, Chairman/ Shinichi Nakane, CEO/ Shinichi Shiota, R & D, METRAN Co., Ltd
Hideo Yamamoto, president, ottimo design co., ltd
Hideo Yamamoto, Takuya Takishita, otthimo design co., ltd
- More information